Canopy Growth (TSX:WEED) Future 3-5Y EPS without NRI Growth Rate : 56.84 (As of May. 21, 2025)

View and export this data going back to 2010. Start your Free Trial

What is Canopy Growth Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Canopy Growth's Future 3-5Y EPS without NRI Growth Rate is 56.84.

Competitive Comparison of Canopy Growth's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Canopy Growth's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Canopy Growth's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Canopy Growth (TSX:WEED) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Canopy Growth Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Canopy Growth's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Canopy Growth Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canopy Growth Corp (TSX:WEED) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

CGC:USA 11L:Germany 11L:Germany 11L:Germany

Address

1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8

Website

https://www.canopygrowth.com

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Executives

David Angelo Lazzarato	Director
Christelle Gedeon	Senior Officer
Judy Eun Joo Hong	Senior Officer
David Eric Klein	Director or Senior Officer of 10% Security Holder
Willy Kruh	Director
Luc Mongeau	Director
Terry Yanofsky	Director
Judy A. Schmeling	Director
Thomas Carlton Stewart	Senior Officer
Rade Nikola Kovacevic	Senior Officer
Phillip Shaer	Senior Officer
Thomas Shipley	Senior Officer
David Bigioni	Senior Officer
Bruce Linton	10% Security Holder, Director, Senior Officer
Mark Anthony Nicholas Zekulin	Senior Officer